Revelation Biosciences
REVB
REVB
12 hedge funds and large institutions have $600K invested in Revelation Biosciences in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
39% less capital invested
Capital invested by funds: $984K → $600K (-$385K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$415K | |
| 2 | +$67.1K | |
| 3 | +$16.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.88K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.61K |
Top Sellers
| 1 | -$101K | |
| 2 | -$43.8K | |
| 3 | -$17.5K | |
| 4 |
HF
HRT Financial
New York
|
-$12K |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$2 |
